Sergej Konoplev Selected Research

Sergej Konoplev Research Topics

Disease

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2007
13	Leukemia 01/2020 - 06/2009
12	Neoplasms (Cancer) 01/2022 - 06/2012
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2011
7	Hypoxia (Hypoxemia) 01/2020 - 01/2011
5	Acute Promyelocytic Leukemia 06/2018 - 12/2007
4	Lymphoma (Lymphomas) 01/2021 - 03/2011
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020 - 10/2007
2	Primary Myelofibrosis (Myelosclerosis) 02/2022 - 05/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 02/2012
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 01/2020
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2021
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021 - 09/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2020 - 11/2013
2	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 01/2016
2	Residual Neoplasm 03/2017 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2014 - 01/2008
2	Paraproteinemias (Monoclonal Gammopathy) 09/2012 - 03/2011
1	Fever of Unknown Origin 01/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Anemia 01/2022
1	Infections 01/2022
1	Hemorrhage 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020
1	Disease Progression 01/2019
1	Cutaneous Mastocytosis 01/2019
1	Hairy Cell Leukemia 12/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Systemic Mastocytosis 10/2016
1	Large Granular Lymphocytic Leukemia 10/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2013

Drug/Important Bio-Agent (IBA)

4	ProdrugsIBA 04/2016 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2012
3	Imatinib Mesylate (Gleevec)FDA Link 10/2016 - 01/2008
2	CreatinineIBA 01/2022 - 10/2011
2	venetoclaxIBA 01/2021 - 12/2018
2	IACS-010759IBA 01/2020 - 01/2018
2	pimonidazoleIBA 01/2020 - 07/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 06/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2018 - 12/2007
2	TH 302IBA 04/2016 - 01/2016
2	Sorafenib (BAY 43-9006)FDA Link 04/2016 - 06/2009
2	NucleophosminIBA 12/2013 - 10/2009
2	CXCR4 Receptors (CXCR4 Receptor)IBA 12/2013 - 03/2007
2	Phosphotransferases (Kinase)IBA 06/2012 - 06/2009
2	TriterpenesIBA 06/2012 - 05/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	AntigensIBA 01/2022
1	nelarabine (506U78)FDA Link 01/2021
1	eltrombopag FDA Link 01/2021
1	Lymphoid Enhancer-Binding Factor 1IBA 12/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	fludarabineIBA 01/2019
1	Busulfan (Busulfex)FDA Link 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	Omalizumab (Xolair)FDA Link 01/2019
1	plerixafor FDA Link 01/2019
1	ibrutinibIBA 12/2018
1	Arsenic Trioxide (Trisenox)FDA Link 06/2018
1	Aspartic Acid (Aspartate)FDA Link 01/2018
1	NucleotidesIBA 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 11/2016
1	GlutaminaseIBA 11/2016
1	IsoenzymesIBA 11/2016
1	Protein Isoforms (Isoforms)IBA 11/2016
1	Cytotoxins (Cytolysins)IBA 04/2016
1	Pharmaceutical PreparationsIBA 04/2016
1	Tyrosine Kinase InhibitorsIBA 04/2016
1	Pyruvic Acid (Pyruvate)IBA 04/2016
1	Core Binding Factor Alpha 2 SubunitIBA 02/2016
1	Rituximab (Mabthera)FDA Link 01/2016
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Biological ProductsIBA 10/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2015
1	LY2510924IBA 07/2015
1	CXC ChemokinesIBA 07/2015
1	Carbonic Anhydrase IXIBA 07/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2015
1	Integrin alpha4beta1 (VLA-4)IBA 04/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2014
1	Dasatinib (BMS 354825)FDA Link 02/2014
1	Monoclonal AntibodiesIBA 11/2013
1	Retinoic Acid Receptor alphaIBA 08/2013
1	OligonucleotidesIBA 08/2013

Therapy/Procedure

14	Therapeutics 01/2022 - 10/2007
9	Drug Therapy (Chemotherapy) 01/2022 - 06/2009
3	Hematopoietic Stem Cell Transplantation 02/2022 - 05/2007
2	Aftercare (After-Treatment) 06/2018 - 05/2015
2	Induction Chemotherapy 01/2018 - 01/2017
1	Transplantation 01/2021
1	Breast Implants (Breast Implant) 01/2020
1	Stem Cell Transplantation 01/2019
1	Immunotherapy 11/2013